Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Viral quasispecies and the problem of vaccine-escape and drug-resistant mutants.
Immunological and virological activity of zalcitabine and zidovudine in combination in HIV-positive people with CD4 cell counts of between 200-500 cells/mm3.
Exploring the functional robustness of an enzyme by in vitro evolution.
Short-term anti-HIV activity of the combination of didanosine and hydroxyurea.
Species-Specific Detection of Vibrio anguillarum in Marine Aquaculture Environments by Selective Culture and DNA Hybridization.
Plasma HIV-1 RNA as a predictor of the efficacy of adding zalcitabine to a previous regimen with zidovudine.
Switching from zidovudine to didanosine in patients with symptomatic HIV infection and disease progression. ddI Iberian Study Group.
[Bronchogenic carcinoma in patients with human immunodeficiency virus infection].
Fate of direct and inverted repeats in the RNA hypermutagenesis reaction.
Quantitative HIV-1 RNA as a marker of clinical stability and survival in a cohort of 302 patients with a mean CD4 cell count of 300 x 10(6)/l.